From GlobeNewswire: 2025-06-27 16:30:00

Quantum BioPharma Ltd. is completing a non-brokered private placement of class A multiple voting shares at $50 per share, expecting to raise up to $600. The Offering will be subscribed for by existing MVS holders, subject to a four-month hold period. The Company plans to use the proceeds for general working capital purposes. The Offering is anticipated to be fully subscribed by Xorax and Fortius, related parties to the Company’s CEO and director, respectively. The Company has filed a material change report and cautions that forward-looking statements involve risks and uncertainties. For more information on Quantum BioPharma, visit their website.



Read more at GlobeNewswire: Quantum BioPharma Announces Private Placement of 12 Class A